Accuray Gross Margin 2012-2026 | ARAY
Current and historical gross margin for Accuray (ARAY) over the last 10 years. The current gross profit margin for Accuray as of March 31, 2026 is %.
| Accuray Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $0.43B | $0.12B | 26.81% |
| 2025-12-31 | $0.44B | $0.12B | 27.92% |
| 2025-09-30 | $0.45B | $0.14B | 31.04% |
| 2025-06-30 | $0.46B | $0.15B | 32.03% |
| 2025-03-31 | $0.47B | $0.15B | 31.40% |
| 2024-12-31 | $0.45B | $0.14B | 31.57% |
| 2024-09-30 | $0.44B | $0.14B | 30.86% |
| 2024-06-30 | $0.45B | $0.14B | 31.84% |
| 2024-03-31 | $0.43B | $0.14B | 33.02% |
| 2023-12-31 | $0.45B | $0.15B | 34.00% |
| 2023-09-30 | $0.46B | $0.16B | 34.95% |
| 2023-06-30 | $0.45B | $0.16B | 34.68% |
| 2023-03-31 | $0.44B | $0.16B | 36.45% |
| 2022-12-31 | $0.42B | $0.16B | 37.41% |
| 2022-09-30 | $0.42B | $0.16B | 37.32% |
| 2022-06-30 | $0.43B | $0.16B | 37.53% |
| 2022-03-31 | $0.43B | $0.16B | 37.67% |
| 2021-12-31 | $0.44B | $0.17B | 38.22% |
| 2021-09-30 | $0.42B | $0.17B | 39.47% |
| 2021-06-30 | $0.40B | $0.16B | 40.40% |
| 2021-03-31 | $0.38B | $0.16B | 41.05% |
| 2020-12-31 | $0.38B | $0.16B | 41.11% |
| 2020-09-30 | $0.38B | $0.15B | 40.11% |
| 2020-06-30 | $0.38B | $0.15B | 39.06% |
| 2020-03-31 | $0.41B | $0.16B | 38.42% |
| 2019-12-31 | $0.41B | $0.16B | 38.39% |
| 2019-09-30 | $0.41B | $0.16B | 38.11% |
| 2019-06-30 | $0.42B | $0.16B | 38.76% |
| 2019-03-31 | $0.42B | $0.16B | 39.52% |
| 2018-12-31 | $0.41B | $0.16B | 38.83% |
| 2018-09-30 | $0.41B | $0.16B | 39.27% |
| 2018-06-30 | $0.41B | $0.16B | 39.75% |
| 2018-03-31 | $0.40B | $0.16B | 38.71% |
| 2017-12-31 | $0.40B | $0.16B | 38.75% |
| 2017-09-30 | $0.39B | $0.15B | 37.89% |
| 2017-06-30 | $0.38B | $0.14B | 36.46% |
| 2017-03-31 | $0.37B | $0.13B | 36.51% |
| 2016-12-31 | $0.38B | $0.14B | 38.40% |
| 2016-09-30 | $0.40B | $0.16B | 39.39% |
| 2016-06-30 | $0.40B | $0.16B | 39.85% |
| 2016-03-31 | $0.41B | $0.16B | 39.90% |
| 2015-12-31 | $0.40B | $0.16B | 39.10% |
| 2015-09-30 | $0.39B | $0.15B | 38.92% |
| 2015-06-30 | $0.38B | $0.15B | 38.16% |
| 2015-03-31 | $0.38B | $0.14B | 37.63% |
| 2014-12-31 | $0.38B | $0.14B | 37.99% |
| 2014-09-30 | $0.38B | $0.14B | 38.40% |
| 2014-06-30 | $0.37B | $0.14B | 38.38% |
| 2014-03-31 | $0.35B | $0.13B | 37.11% |
| 2013-12-31 | $0.33B | $0.11B | 33.94% |
| 2013-09-30 | $0.31B | $0.10B | 32.15% |
| 2013-06-30 | $0.32B | $0.10B | 30.91% |
| 2013-03-31 | $0.33B | $0.11B | 32.13% |
| 2012-12-31 | $0.36B | $0.12B | 33.79% |
| 2012-09-30 | $0.39B | $0.14B | 34.69% |
| 2012-06-30 | $0.41B | $0.14B | 33.25% |
| 2012-03-31 | $0.38B | $0.13B | 34.46% |
| 2011-12-31 | $0.34B | $0.12B | 36.61% |
| 2011-09-30 | $0.28B | $0.11B | 39.44% |
| 2011-06-30 | $0.22B | $0.11B | 47.75% |
| 2011-03-31 | $0.21B | $0.11B | 50.24% |
| 2010-12-31 | $0.21B | $0.10B | 50.00% |
| 2010-09-30 | $0.21B | $0.10B | 47.85% |
| 2010-06-30 | $0.22B | $0.10B | 46.85% |
| 2010-03-31 | $0.22B | $0.10B | 45.66% |
| 2009-12-31 | $0.23B | $0.11B | 46.05% |
| 2009-09-30 | $0.23B | $0.11B | 47.16% |
| 2009-06-30 | $0.23B | $0.11B | 48.72% |
| 2009-03-31 | $0.23B | $0.11B | 50.44% |
| 2008-12-31 | $0.22B | $0.11B | 49.11% |
| 2008-09-30 | $0.22B | $0.11B | 50.00% |
| 2008-06-30 | $0.21B | $0.11B | 50.71% |
| 2008-03-31 | $0.20B | $0.11B | 51.47% |
| 2007-12-31 | $0.18B | $0.10B | 54.95% |
| 2007-09-30 | $0.16B | $0.09B | 55.77% |
| 2007-06-30 | $0.14B | $0.08B | 57.14% |
| 2007-03-31 | $0.11B | $0.06B | 55.36% |
| 2006-12-31 | $0.09B | $0.05B | 54.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.046B | $0.459B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |